Vir Biotechnology Stock Widgets and Gadgets
VIR Stock | USD 7.96 0.10 1.27% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- VIR Vir Biotechnology
- Latest Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference
- VIR 7.96 0.1
- Low 7.66
- High 8.0
- Alpha -0.3
- Beta 2.48
- Return On Equity -0.37
- Return On Asset -0.19
- Operating Margin (91.85) %
- Current Valuation 294.59 M
- Shares Outstanding 137.72 M
- Shares Owned By Insiders 11.90 %
- Shares Owned By Institutions 74.45 %
- Number Of Shares Shorted 5.51 M
- Price To Earning 3.16 X
- Price To Book 0.88 X
- Price To Sales 13.94 X
- Revenue 86.18 M
- Gross Profit 1.03 B
- EBITDA (664.85 M)
- Net Income (615.06 M)
- Cash And Equivalents 2.2 B
- Cash Per Share 16.55 X
- Total Debt 124.54 M
- Debt To Equity 0.07 %
- Current Ratio 4.79 X
- Book Value Per Share 9.08 X
- Cash Flow From Operations (778.78 M)
- Short Ratio 4.36 X
- Earnings Per Share (3.93) X
- Price To Earnings To Growth 1.14 X
- Target Price 29.5
- Number Of Employees 587
- Beta 0.46
- Market Capitalization 1.1 B
- Total Asset 1.92 B
- Retained Earnings (237.82 M)
- Working Capital 1.41 B
- Net Asset 1.92 B
- Accumulation Distribution 0.0425
- Daily Balance Of Power 0.2941
- Rate Of Daily Change 1.01
- Day Median Price 7.83
- Day Typical Price 7.87
- Market Facilitation Index 0.34
- Price Action Indicator 0.18
- Period Momentum Indicator 0.1
Market Snapshot Widget Example
DAX Index Germany | 19,626 1.03 | |
Taiwan Weighted Taiwan | 22,262 0.16 | |
PSI 20 Stock Portugal | 6,418 0.2 | |
CROBEX Croatia | 3,162 0.09 | |
Budapest SE Hungary | 77,936 0.56 | |
IDX 30 Jakarta Indonesia | 438.73 2.01 | |
ISEQ 20 Price Ireland | 1,611 1.06 | |
NYSE Comp USA | 20,272 0.31 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,080 2.35 | |
IPC MEXICO Mexico | 49,710 0.21 | |
KL Technology Malaysia | 58.48 0.43 | |
IBEX 35 Index Spain | 11,641 0.26 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,539 0.30 | |
SPASX Dividend Opportunities Australia | 1,697 0.03 | |
HNX 30 Vietnam | 479.79 0.88 | |
Bucharest BET-NG Romania | 1,193 1.43 | |
AMS Small Cap Netherlands | 1,227 1.00 | |
Oslo Exchange Mutual Norway | 1,410 0.22 | |
BEL Small Belgium | 8,012 0.4 | |
Basic Materials Brazil | 5,874 1.78 | |
Swiss Leader Price Switzerland | 1,941 0.51 | |
Fondo Mutuo ETF Chile | 1,367 0.39 | |
Athens General Comp Greece | 1,393 0.74 | |
Stock Exchange Of Thailand | 1,428 0.03 | |
PX Prague Stock Czech Repub | 1,682 0.33 | |
THE PHILIPPINE STOCK Philippines | 6,614 0.37 | |
WIG 30 Poland | 2,809 0.30 | |
BIST Electricity Turkey | 490.89 0.35 |
Investing Ideas
In addition to having Vir Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Vir Biotechnology
Compare Vir Biotechnology To Peers
Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.